Prescription Drugs

• KFF Health News: Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice

  September 21, 2023: Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, ...Read more >

• Alliance Members Spread the Word about the Benefits of Medicare Drug Price Negotiation

  September 07, 2023: Days after the Biden-Harris administration unveiled the list of 10 prescription drugs that will be subject to Medicare price negotiation, Alliance members across the country joined elected leaders and Cabinet officials to inform older Americans about...Read more >

• White House Announces First 10 Drugs Up for Medicare Price Negotiation

  September 01, 2023: On Tuesday, the Biden-Harris administration unveiled a list of the 10 prescription drugs that Medicare will negotiate lower prices for with drug corporations. The list has several drugs that many seniors use, including Eliquis and Xarelto, which a...Read more >

• Retirees Applaud Release of the First Ten Drugs That Medicare Will Negotiate Prices For With Drug Corporations

  August 29, 2023: Statement by Richard Fiesta, Executive Director of the Alliance for Retired Americans on the Centers for Medicare and Medicaid Services’ release of the first ten drugs that will be subject to price negotiation. “It’s a landmark day for older...Read more >

• White House to Name First 10 Drugs for Medicare Negotiations Next Week

  August 25, 2023: The Biden-Harris administration plans to unveil the first 10 drugs selected for Medicare price negotiations Tuesday, in a milestone in the president’s plan to lower the price of prescription drugs. Democrats in the House and Senate passed legisl...Read more >

• Fact Sheet: The Inflation Reduction Act and Prescription Drug Prices

  August 25, 2023: One in four people over the age of 65 report not taking at least one prescription drug as prescribed due to its cost. Meanwhile, pharmaceutical corporations are making record profits, lining the pockets of their executives and shareholders while pati...Read more >

• KFF Health News: New Alzheimer’s Drug Raises Hopes — Along With Questions

  August 17, 2023: The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment. Medicare has said it will pay for the therapy. Medical centers across the country are scrambling t...Read more >

• KFF Health News: The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

  August 03, 2023: The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors most likely to suffer from dementia. Medica...Read more >

• Retirees Concerned on Eve of Medicare’s 58th Anniversary

  July 28, 2023: Washington, DC - Members of the Alliance for Retired Americans are marking the anniversary of Medicare and urging older Americans to be vigilant and ready to fight any attempts to raise the eligibility age or cut their earned health care benefits. ...Read more >

• KFF Health News: New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors

  July 27, 2023: Corlee Morris has dieted throughout her adult life. After her weight began climbing in high school, she spent years losing 50 or 100 pounds then gaining it back. Morris, 78, was at her heaviest in her mid-40s, standing 5 feet 10½ inches and weigh...Read more >